Skip to main content
. 2019 Dec 9;92:100573. doi: 10.1016/j.curtheres.2019.100573

Table 8.

Pharmacokinetic results. Dose-level: 1 mg/animal.

Analyte Matrix Rsq No. of points used to calculate λz λz t1/2 (90% CI)* Tmax Cmax C0 AUC0–t AUC0–∞ AUCt–∞ extrapolated
1/h h h µg-eq/g µg-eq/g h*µg-eq/g h*µg-eq/g %
HA Knee 0.957 3 0.0061 114 (101–131) 6 na 736 21,223 21,647 2
na 2 0.0053 131 (77–441) nc nc
HA Plasma 0.995 4 0.0088 79 (57–130) 24 7.47 na 989 1127 12
na 2 0.0054 129 (102–174) nc nc
CS Knee 0.989 3 0.0085 82 (69–99) 6 na 80.9 4746 5051 6
na 2 0.0056 125 (67–845) nc nc
CS Plasma 0.971 4 0.0079 88 (74–109) 1 4.90 na 39.8 40.8 3
na 2 0.0056 124 (87–218) nc nc

CS = chondroitin sulfate; HA = hyaluronic acid; na = not applicable; nc = not calculated; Rsq = R-squared; λz = elimination time constant; t1/2 = half-life; CI = confidence interval; C0 = concentration at time zero (extrapolated); Cmax = maximal concentration; Tmax = time for maximal reading; AUC = area under the curve.

Calculated using R version 3.6.1. (R Foundation for Statistical Computing, Vienna, Austria).